Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
---|
06/29/2000 | WO1998050067A3 Use or a secretion vector for fertility control by oral vaccination |
06/29/2000 | CA2356452A1 Compositions and methods for reducing or preventing fertilization in fish and birds |
06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
06/29/2000 | CA2356181A1 Triazineone compounds for treating diseases due to sarcocystis, neospora and toxoplasma |
06/29/2000 | CA2355861A1 Amide and urea derivatives as 5-ht reuptake inhibitors and as 5-ht1b/1d ligands |
06/29/2000 | CA2355368A1 Cgmp pde 5 inhibitors for inhalation in the treatment of sexual dysfunction |
06/29/2000 | CA2355251A1 New .beta.-amide and .beta.-sulfonamide carboxylic acid derivatives, their preparation and their use as endothelin receptor antagonists |
06/29/2000 | CA2355148A1 Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions |
06/29/2000 | CA2355137A1 Non-peptide nk1 receptors antagonists |
06/29/2000 | CA2353907A1 Fused 1,2,4-thiadiazine derivatives, their preparation and use |
06/28/2000 | EP1013639A1 Aryl carboxylic acid and tetrazole derivatives comprising a carbamoyloxy unit |
06/28/2000 | EP1013275A2 Method and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine |
06/28/2000 | EP1012273A2 Secreted proteins and polynucleotides encoding them |
06/28/2000 | EP1012176A1 Sperm specific antigens 4.1 and 6.7, dna encoding them and contraceptive vaccines comprising said sperm antigens |
06/28/2000 | EP1012154A2 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
06/28/2000 | EP1011721A1 Vaginal lactobacillus medicant |
06/28/2000 | EP1011695A1 Use of neurotoxin therapy for treatment of urologic and related disorders |
06/28/2000 | EP1011682A2 Hormonal contraceptive |
06/28/2000 | EP1011681A1 Oral contraceptive preparation having a first phase comprising progestin/estrogen and a second phase comprising progestin |
06/28/2000 | EP1011667A1 Antagonists of gonadotropin releasing hormone |
06/28/2000 | EP1011636A1 New foam-forming pharmaceutical composition |
06/28/2000 | EP1011632A2 A pharmaceutical composition for treating dysmenorrhea and premature labor |
06/28/2000 | CN1258286A Non-steroidal (hetero) cyclically substd. acylanilides with mixed gestagen and androgen activity |
06/28/2000 | CN1257864A Imidazoline compound, preparing process thereof and pharmaceutical composition contg. same |
06/28/2000 | CN1257728A Medical capsule for building up body and invigorating function of kidney |
06/28/2000 | CN1053904C N-pyridyl carboxamides and derivs. processes for their preparation and pharmaceutical compositions contg. them |
06/28/2000 | CN1053886C Naphthyl compounds, intermediates and their preparing method and use |
06/28/2000 | CN1053833C Kidney-reinforcing Yang-strengthening powder |
06/28/2000 | CN1053829C Method for preparation of Chinese medicine for gynecopathy |
06/27/2000 | US6080841 Human induced tumor protein |
06/27/2000 | US6080774 Substituted biphenylsulfonamide endothelin antagonists |
06/27/2000 | US6080764 Superoxide radical inhibitor |
06/27/2000 | US6080761 Inhibition of smooth muscle cell migration by (R)-amlodipine |
06/27/2000 | US6080754 For treatment and prophylaxis of estrogen related syndromes and disorders |
06/27/2000 | US6080735 Estra-1,3,5(10)-trien derivatives, processes for their preparation and pharmaceutical compositions containing these compounds |
06/27/2000 | CA2198564C Method of reducing tissue damage associated with non-cardiac ischemia |
06/23/2000 | CA2596416A1 Methods of extended use oral contraception |
06/22/2000 | WO2000036104A1 Pancreatic polypeptide zsig66 |
06/22/2000 | WO2000035938A1 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity |
06/22/2000 | WO2000035919A2 Quinoline derivatives |
06/22/2000 | WO2000035907A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
06/22/2000 | WO2000035892A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity |
06/22/2000 | WO2000035891A1 Morpholinone and morpholine derivatives and uses thereof |
06/22/2000 | WO2000035878A1 1,4-piperazine derivatives having 5ht1a receptor activity |
06/22/2000 | WO2000035875A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity |
06/22/2000 | WO2000035465A2 Oral administration of lactobacillus for the treatment and prevention of urogenital infection |
06/22/2000 | WO2000035463A1 Method for producing a material containing cells from the prostate gland, material containing cells from the prostate gland and methods for treating uterus fibromatosis, chronic prostatitis and disorders of the male sexual function according to a transplantation technique |
06/22/2000 | WO2000035457A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
06/22/2000 | WO2000016632A3 Environmentally benign crop protection agents |
06/22/2000 | WO2000012504A3 Dihydro-[1,2,3]triazolo-[4,5-d]pyrimidin-7-one |
06/22/2000 | WO1999054707A3 Fetal testing for prediction of low birth weight |
06/22/2000 | WO1999038504A8 Pharmaceutical uses of optically pure (-)-bupropion |
06/22/2000 | CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
06/22/2000 | CA2355234A1 Quinoline derivatives |
06/22/2000 | CA2355202A1 Imidazolones and their use in treating benign prostatic hyperplasia and other disorders |
06/22/2000 | CA2355201A1 Morpholinone and morpholine derivatives and uses thereof |
06/22/2000 | CA2355039A1 Pancreatic polypeptide zsig66 |
06/22/2000 | CA2354601A1 Use of apomorphine in the manufacture of a medicament for the treatment of organic erectile dysfunction in males |
06/22/2000 | CA2352337A1 22s-hydroxycholesta-8, 14-diene derivatives with meiosis regulating activity |
06/22/2000 | CA2351860A1 Piperazine ethylamide derivatives with 5-ht1a receptor activity |
06/22/2000 | CA2351859A1 1,4-piperazine derivatives having 5ht1a receptor activity |
06/22/2000 | CA2351400A1 Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1a receptor activity |
06/22/2000 | CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
06/21/2000 | EP1010694A2 Spiroimidazoline derivatives and their use as alpha2-adrenergic antagonists and monoamines-reuptake blockers |
06/21/2000 | EP1010693A1 Imidazoline derivatives, preparation and pharmaceutical compositions containing them |
06/21/2000 | EP1010431A2 Botulinum toxins for treating pain associated with muscle spasms |
06/21/2000 | EP1009762A2 Lipocalin homologs |
06/21/2000 | EP1009737A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
06/21/2000 | EP1009730A1 New pentaerythritol derivatives, their production and use and intermediates for their synthesis |
06/21/2000 | EP1009428A1 Vaginal suppository vaccine for urogenital infections |
06/21/2000 | EP1009414A2 Novel pharmaceutical composition |
06/21/2000 | EP1009384A1 A method of administering liposomal encapsulated taxane |
06/21/2000 | DE19858779A1 New 3-acylamino-propionic acid and 3-sulfonylamino-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiovascular and renal disorders, migraine and cancer |
06/21/2000 | CN1257499A 8-Azabicyclo (3,2,1) oct-2-ene and octane derivatives as cholinergic ligands at nicotinic ACH receptors |
06/21/2000 | CN1256941A Traditional Chinese medicine for treating hydroperididymia and funicular hydrocele and preparation process thereof |
06/21/2000 | CN1256917A Method for rasing sow conception, farrowing and surical rate by using vitamin E |
06/21/2000 | CN1053672C Azasteroid compounds for treating prostatic hypertrophy, their preparation and use |
06/21/2000 | CN1053585C Medicine for treating prostate diseases |
06/20/2000 | US6077873 Steroid compounds having contraceptive and anti-osteoporosis activity |
06/20/2000 | US6077841 For treating sexual disorders, male impotency, heart failure, pulmonary hypertension, and angina |
06/20/2000 | CA2198536C Method of reducing tissue damage associated with ischemia |
06/20/2000 | CA2198535C Method of increasing testosterone |
06/20/2000 | CA2001618C Gestodene-containing agent for transdermal administration |
06/20/2000 | CA1341029C Peptidase inhibitors |
06/15/2000 | WO2000034498A1 Two-step immunization procedure against chlamydia infection |
06/15/2000 | WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS) |
06/15/2000 | WO2000034472A1 Spermatogenesis protein |
06/15/2000 | WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF |
06/15/2000 | WO2000034248A1 New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents |
06/15/2000 | WO2000034244A1 3-substituted-4-arylquinolin-2-one derivatives as potassium channel modulators |
06/15/2000 | WO2000034228A1 Ion channel modulating agents |
06/15/2000 | WO2000033845A1 Remedial agent for erectile dysfunction |
06/15/2000 | WO2000033840A1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis |
06/15/2000 | WO2000033834A1 Use of isatin derivatives as ion channel activating agents |
06/15/2000 | WO2000033828A1 Agent for lowering endothelin levels |
06/15/2000 | WO2000033825A2 Compositions and methods for amelioration of human female sexual dysfunction |
06/15/2000 | WO2000010536A8 Extended release buccal bioadhesive tablet |
06/15/2000 | WO2000006531A3 Nitric esters and nitrate salts of specific drugs |
06/15/2000 | CA2354035A1 Use of acetylcholinesterase inhibitors on the modulation of the hypothalamic-pituitary-gonadal axis |
06/15/2000 | CA2353525A1 Drug targets in candida albicans |